Kaori Yamada‐Nomoto

No ORCID on file · 6 papers in corpus · active 2016-2020

Study types

  • article 6

Condition tags

  • endometriosis 5
  • endometrioma 1
article 2020
Biomedicines ·doi:10.3390/biomedicines8110467

Background: Relaxin (RLX)-2, produced by the corpus luteum and placenta, is known to be potentially effective in fibrotic diseases of the heart, lungs, kidneys, and bladder; however, its effectiveness in endometriosis has not yet been inves…

article 2019
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719119828112
article 2017
European journal of pain (London, England) ·doi:10.1002/ejp.1133

BACKGROUND: Endometriosis is a gynaecological disease exhibiting severe pelvic pain, but the mechanism of pain production remains unknown. Bradykinin (BK) is known as an inflammatory mediator, and shows elevated levels in inflammatory disea…

article 2016
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.12592

OBJECTIVE: We investigated α-7 nAchR expression in human peritoneal macrophages and examined whether activation of nAchR might be a new therapy for endometriosis. MATERIALS AND METHODS: Human peritoneal fluid mononuclear cells (PFMC) were s…

article 2016
·doi:10.1111/jog.13226

AIM: Recent investigations have demonstrated that athletes with high relaxin-2 levels have a high risk of anterior cruciate ligament injuries, while athletes taking oral contraceptives (OC) have low relaxin-2 levels. It has not yet been cla…

article 2016
·doi:10.1016/j.jri.2016.10.054